SB-007
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB-007, covering 2025-04-29 to 2025-04-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) [Phase 1, Phase 2]